These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1670739)

  • 1. Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea.
    Sajatovic M; Verbanac P; Ramirez LF; Meltzer HY
    Neurology; 1991 Jan; 41(1):156. PubMed ID: 1670739
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.
    van Vugt JP; Siesling S; Vergeer M; van der Velde EA; Roos RA
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):35-9. PubMed ID: 9221965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
    Edlinger M; Seppi K; Fleischhacker W; Hofer A
    Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintained improvement with minocycline of a patient with advanced Huntington's disease.
    Denovan-Wright EM; Devarajan S; Dursun SM; Robertson HA
    J Psychopharmacol; 2002 Dec; 16(4):393-4. PubMed ID: 12503842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine in Huntington's chorea.
    Bonuccelli U; Ceravolo R; Maremmani C; Nuti A; Rossi G; Muratorio A
    Neurology; 1994 May; 44(5):821-3. PubMed ID: 8190281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
    Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J
    J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease.
    Yavuz KF; Ulusoy S; Alnıak İ
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E31. PubMed ID: 23686053
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease.
    Lin WC; Chou YH
    Am J Psychiatry; 2008 Sep; 165(9):1207-8. PubMed ID: 18765501
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine for the treatment of agitated-depressed patients with cognitive impairment: a report of three cases.
    Nacasch N; Dolberg OT; Hirschmann S; Dannon P; Grunhaus LJ
    Clin Neuropharmacol; 1998; 21(2):132-4. PubMed ID: 9579302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic management of a patient with Huntington's chorea.
    Nandita K; Jatin L; Sarla H
    Neurol India; 2008; 56(4):486-7. PubMed ID: 19127052
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic drugs in Huntington's disease.
    Unti E; Mazzucchi S; Palermo G; Bonuccelli U; Ceravolo R
    Expert Rev Neurother; 2017 Mar; 17(3):227-237. PubMed ID: 27534434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the treatment studies in Huntington's disease since 1990.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2007 Feb; 8(2):141-53. PubMed ID: 17257085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reaction on 'Psychiatric problems in a motor disorder: psychosis in Huntington's disease'].
    van Duijn E
    Tijdschr Psychiatr; 2015; 57(8):624. PubMed ID: 26402899
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior.
    Raja M; Soleti F; Bentivoglio AR
    Mov Disord; 2015 Sep; 30(10):1438. PubMed ID: 26207615
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptically induced dystonia in Huntington's disease: a case report.
    Schott K; Ried S; Stevens I; Dichgans J
    Eur Neurol; 1989; 29(1):39-40. PubMed ID: 2523309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the neuroleptic-nonresponsive schizophrenic patient.
    Meltzer HY
    Schizophr Bull; 1992; 18(3):515-42. PubMed ID: 1357741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.